The effect of blueberry interventions on cognitive performance and mood: A systematic review of randomized controlled trials.


Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
03 2020
Historique:
received: 10 12 2018
revised: 20 02 2019
accepted: 02 04 2019
pubmed: 19 4 2019
medline: 28 4 2021
entrez: 19 4 2019
Statut: ppublish

Résumé

Blueberries are rich in polyphenols that may be beneficial to cognitive performance and mood. The aim of this systematic review was to evaluate randomized controlled trials investigating the effects of blueberries and blueberry products on measures of cognition and mood. In total, eleven articles (that included 12 studies) were identified using freeze-dried blueberries (n = 9 studies), whole blueberries (n = 2) and blueberry concentrate (n = 1). These studies were conducted in children (n = 5), young adults (n = 1), and older people with either no known cognitive impairment (n = 4) or indicated cognitive impairment (n = 2). Eight studies reported blueberry consumption or supplementation at various doses and time lengths to improve measures of cognitive performance, particularly short- and long-term memory and spatial memory. For mood, one study reported significant between-group improvements in positive affect from blueberry products, whereas four studies reported no improvement. Low risk of bias were observed across all studies. Based on the current evidence, blueberries may improve some measures of cognitive performance. However, considerable differences in study design, dosages, and anthocyanin content hinder between-study comparison. The use of standardized blueberry interventions, consideration of placebo formulations, and consistently reported cognitive performance tools are recommended in future trials. PROSPERO registration no. CRD42018100888.

Identifiants

pubmed: 30999017
pii: S0889-1591(18)31195-4
doi: 10.1016/j.bbi.2019.04.001
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

96-105

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Nikolaj Travica (N)

Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, VIC 3122, Australia.

Nathan M D'Cunha (NM)

Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia; Collaborative Research in Bioactives and Biomarkers (CRIBB) Group, Canberra, ACT 2617, Australia.

Nenad Naumovski (N)

Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia; Collaborative Research in Bioactives and Biomarkers (CRIBB) Group, Canberra, ACT 2617, Australia.

Katherine Kent (K)

Centre for Rural Health, College of Health and Medicine, University of Tasmania, Launceston 7250, Tasmania, Australia.

Duane D Mellor (DD)

Collaborative Research in Bioactives and Biomarkers (CRIBB) Group, Canberra, ACT 2617, Australia.

Joseph Firth (J)

NICM Health Research Institute, Western Sydney University, Campbelltown, NSW 2560, Australia; Division of Psychology and Mental Health, University of Manchester, Manchester M13 9PL, United Kingdom.

Ekavi N Georgousopoulou (EN)

Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia; Collaborative Research in Bioactives and Biomarkers (CRIBB) Group, Canberra, ACT 2617, Australia; Australian National University Medical School, Australian National University, Canberra, ACT 2605, Australia.

Olivia M Dean (OM)

IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria 3216, Australia; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria 3052, Australia; Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria 3050, Australia.

Amy Loughman (A)

IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria 3216, Australia.

Felice Jacka (F)

IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria 3216, Australia.

Wolfgang Marx (W)

IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria 3216, Australia. Electronic address: wolf.marx@deakin.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH